These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 12006976

  • 1. In vivo developmental stages in murine natural killer cell maturation.
    Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM.
    Nat Immunol; 2002 Jun; 3(6):523-8. PubMed ID: 12006976
    [Abstract] [Full Text] [Related]

  • 2. Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cells.
    Maeda M, Uchida N, Eaves CJ, Takei F.
    Exp Hematol; 2003 Nov; 31(11):1015-8. PubMed ID: 14585363
    [Abstract] [Full Text] [Related]

  • 3. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
    Tay CH, Yu LY, Kumar V, Mason L, Ortaldo JR, Welsh RM.
    J Immunol; 1999 Jan 15; 162(2):718-26. PubMed ID: 9916691
    [Abstract] [Full Text] [Related]

  • 4. Diversity of NK cell receptor repertoire in adult and neonatal mice.
    Kubota A, Kubota S, Lohwasser S, Mager DL, Takei F.
    J Immunol; 1999 Jul 01; 163(1):212-6. PubMed ID: 10384118
    [Abstract] [Full Text] [Related]

  • 5. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets.
    Toomey JA, Salcedo M, Cotterill LA, Millrain MM, Chrzanowska-Lightowlers Z, Lawry J, Fraser K, Gays F, Robinson JH, Shrestha S, Dyson PJ, Brooks CG.
    J Immunol; 1999 Sep 15; 163(6):3176-84. PubMed ID: 10477585
    [Abstract] [Full Text] [Related]

  • 6. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH, Maeda M, Lohwasser S, Delcommenne M, Nakano T, Vance RE, Raulet DH, Takei F.
    J Immunol; 2002 May 15; 168(10):4980-7. PubMed ID: 11994449
    [Abstract] [Full Text] [Related]

  • 7. Distinct receptor repertoire formation in mouse NK cell subsets regulated by MHC class I expression.
    Hayakawa Y, Watt SV, Takeda K, Smyth MJ.
    J Leukoc Biol; 2008 Jan 15; 83(1):106-11. PubMed ID: 17940219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A.
    Salmon-Divon M, Höglund P, Johansson MH, Johansson S, Mehr R.
    Mol Immunol; 2005 Feb 15; 42(4):397-403. PubMed ID: 15607790
    [Abstract] [Full Text] [Related]

  • 10. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression.
    Williams NS, Kubota A, Bennett M, Kumar V, Takei F.
    Eur J Immunol; 2000 Jul 15; 30(7):2074-82. PubMed ID: 10940897
    [Abstract] [Full Text] [Related]

  • 11. Functional analysis of natural killer cell receptors in the RNK-16 rat leukemic cell line.
    Ryan JC, Niemi EC, Nakamura MC.
    Methods Mol Biol; 2000 Jul 15; 121():283-95. PubMed ID: 10818734
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y.
    J Reprod Immunol; 2006 Jun 15; 70(1-2):33-42. PubMed ID: 16488482
    [Abstract] [Full Text] [Related]

  • 14. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K, Stevenaert F, De Creus A, Debacker V, De Boever J, Plum J, Leclercq G.
    J Immunol; 2001 Apr 01; 166(7):4302-11. PubMed ID: 11254682
    [Abstract] [Full Text] [Related]

  • 15. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E, Kristensson K, Ljunggren HG.
    Scand J Immunol; 2004 Apr 01; 60(1-2):14-22. PubMed ID: 15238069
    [Abstract] [Full Text] [Related]

  • 16. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.
    Fraser KP, Gays F, Robinson JH, van Beneden K, Leclercq G, Vance RE, Raulet DH, Brooks CG.
    Eur J Immunol; 2002 Mar 01; 32(3):868-78. PubMed ID: 11870631
    [Abstract] [Full Text] [Related]

  • 17. Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-beta receptor expression.
    Stevenaert F, Van Beneden K, De Colvenaer V, Franki AS, Debacker V, Boterberg T, Deforce D, Pfeffer K, Plum J, Elewaut D, Leclercq G.
    Blood; 2005 Aug 01; 106(3):956-62. PubMed ID: 15827137
    [Abstract] [Full Text] [Related]

  • 18. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.
    Eur J Immunol; 2003 Jun 01; 33(6):1657-66. PubMed ID: 12778484
    [Abstract] [Full Text] [Related]

  • 19. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
    Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE.
    Mol Immunol; 2005 Feb 01; 42(4):485-8. PubMed ID: 15607803
    [Abstract] [Full Text] [Related]

  • 20. Ly49 and CD94/NKG2: developmentally regulated expression and evolution.
    Takei F, McQueen KL, Maeda M, Wilhelm BT, Lohwasser S, Lian RH, Mager DL.
    Immunol Rev; 2001 Jun 01; 181():90-103. PubMed ID: 11513155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.